Vivinavi : World : () World

header




CMS Seeks Feedback on Medicare $2 Drug List Model, Sample $2 Drug List, and Outreach

Today, the U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), released a Request for Information (RFI) [ https://links-2.govdelivery.com/CL0/https:%2F%2Fwww.cms.gov%2Ffiles%2Fdocument%2Fm2dl-model-rfi.pdf/1/01010192716131aa-5c2ca403-9702-4ddc-9d1f-962d064d77d7-000000/zU1aDfI_XY1OCifMaghGH8tDrxGg0IlibOo0veOn03s=374 ] and a sample list of prescription drugs that the agency preliminarily intends to include under the proposed Medicare $2 Drug List Model, which was developed in accordance with President Biden’s Executive Order 14087, “Lowering Prescription Drug Costs for Americans."

Under the model, people enrolled in a participating Medicare prescription drug coverage (Part D) plan would have access to these drugs for a low, fixed copayment of no more than $2 for a month’s supply per drug. The model would provide individuals more certainty about the out-of-pocket costs for these generic covered Part D drugs that treat common medical conditions. CMS issued this RFI to support continued development of the model.

The Center for Medicare and Medicaid Innovation’s (Innovation Center's) Medicare $2 Drug List Model aims to test whether a simplified approach to offering low-cost, clinically important generic drugs can:


* Improve medication adherence,
* Lead to better health outcomes, and
* Improve satisfaction with the Part D prescription drug benefit among people with Medicare and prescribers.

Participation in the model would be voluntary for Part D sponsors and, pending further development, could start as early as January 2027.

Details on the Medicare $2 Drug List Request for Information can be found at Medicare $2 Drug List webpage [ https://links-2.govdelivery.com/CL0/https:%2F%2Fwww.cms.gov%2Fpriorities%2Finnovation%2Finnovation-models%2Fmedicare-two-dollar-drug-list-model/1/01010192716131aa-5c2ca403-9702-4ddc-9d1f-962d064d77d7-000000/mBIuyU3Wm2Kf2pnmAD5_gr8FWqxaY71u24WHjRjlDZQ=374 ]. Additional details on the Medicare $2 Drug List Model were also  released in October 2023 in the “CMS Innovation Center’s One-Year Update on the Executive Order to Lower Prescription Drug Costs for Americans [ https://links-2.govdelivery.com/CL0/https:%2F%2Fwww.cms.gov%2Fblog%2Fcms-innovation-centers-one-year-update-executive-order-lower-prescription-drug-costs-americans/1/01010192716131aa-5c2ca403-9702-4ddc-9d1f-962d064d77d7-000000/g-CNq9Mqk9txBs9Bs2veRf07gT4E1-O3Ezi-yk9K38w=374 ]” blog post.

Information on how to submit comments can be found on https://surveys.cms.gov/jfe/form/SV_40iDHQWMNuVfyGq [ https://links-2.govdelivery.com/CL0/https:%2F%2Fsurveys.cms.gov%2Fjfe%2Fform%2FSV_40iDHQWMNuVfyGq/1/01010192716131aa-5c2ca403-9702-4ddc-9d1f-962d064d77d7-000000/mhiwTQRu3pUxYbMbC_BQw2vzyZrMyi9kZzG3wBa5yKQ=374 ]. Comments must be submitted by December 9, 2024, and will only be accepted through the link above.








________________________________________________________________________

You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov/ ].

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page [ https://public.govdelivery.com/accounts/USCMS/subscriber/edit?preferences=true#tab1 ]. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com [ https://subscriberhelp.govdelivery.com/ ].

This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov ].


________________________________________________________________________

This email was sent to mshinji3056@gmail.com using GovDelivery Communications Cloud 7500 Security Boulevard · Baltimore MD 21244


body .abe-column-block { min-height: 5px; } table.gd_combo_table img {margin-left:10px; margin-right:10px;} table.gd_combo_table div.govd_image_display img, table.gd_combo_table td.gd_combo_image_cell img {margin-left:0px; margin-right:0px;} table.govd_hr {min-width: 100%;}